Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

New gastric acid antisecretory agents emerge from Altana Pharma R&D

June 27, 2006

Enrollment completed in celgosivir phase IIb combination study in HCV

June 19, 2006

Recent patents disclose new anti-HCV compounds

June 14, 2006

MRX-5 improves IBD symptoms in preclinical studies

June 13, 2006

N297A: A new anti-mouse CD3 Fc-modified antibody for chronic inflammatory diseases

June 12, 2006

Glatiramer acetate and TV-5010 suppress ulcerative colitis in preclinical studies

June 12, 2006

Bavituximab shows signs of antiviral activity in HCV patients

June 12, 2006

Preclinical characteristics of HCV protease inhibitor ITMN-191 described

June 9, 2006

Agents for gastrointestinal disorders claimed in recent patents

June 8, 2006

Development plans for three dosage forms of methylnaltrexone

June 8, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 8, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Hyperexcitability may be joint problem in epilepsy, dementia
BioWorld
The majority of epilepsies are developmental disorders that start in childhood. But there is a large minority that starts in late adulthood. And increasingly,...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
GDE4 blockade promotes remyelination, study finds
BioWorld Science
Myelin is crucial for the correct functioning of nerve signaling and its loss is a feature of neurological disorders. The cells responsible for myelination in the...